FINAL MASTER’S EXAMINATION  - Oiza Blessing Aliu

Health and Pharmaceutical Outcomes MS Candidate
“Sotorasib vs. Docetaxel in Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation: 
Cost-effectiveness and Value of Information Analyses”

Attend in-person, or join virtually here.